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Summary
Background: In Drosophila, the basic-helix-loop-helix protein
DIMM coordinates the molecular and cellular properties of all
major neuroendocrine cells, irrespective of the secretory
peptides they produce. When expressed by nonneuroendo-
crine neurons, DIMM confers the major properties of the regu-
lated secretory pathway and converts such cells away from
fast neurotransmission and toward a neuroendocrine state.
Results: We first identified 134 transcripts upregulated by
DIMM in embryos and then evaluated them systematically using
diverse assays (including embryo in situ hybridization, in vivo
chromatin immunoprecipitation, and cell-based transactivation
assays). We conclude that of eleven strong candidates, six are
strongly and directly controlled by DIMM in vivo. The six targets
include several large dense-core vesicle (LDCV) proteins, but
also proteins in non-LDCV compartments such as the RNA-
associated protein Maelstrom. In addition, a functional in vivo
assay, combining transgenic RNA interference with MS-based
peptidomics, revealed that three DIMM targets are especially
critical for its action. These include two well-established LDCV
proteins, the amidation enzyme PHM and the ascorbate-regen-
erating electron transporter cytochrome b561-1. The third key
DIMM target, CAT-4 (CG13248), has not previously been asso-
ciated with peptide neurosecretion—it encodes a putative
cationic amino acid transporter, closely related to the Slimfast
arginine transporter. Finally, we compared transcripts upregu-
lated by DIMM with those normally enriched in DIMM neurons
of the adult brain and found an intersection of 18 DIMM-regu-
lated genes, which included all six direct DIMM targets.
Conclusions: The results provide a rigorous molecular
framework with which to describe the fundamental regulatory
organization of diverse neuroendocrine cells.
Introduction
Neuroendocrine (NE) cells embody highly dedicated secretory
cell states. Although different NE cells express unique arrays6These authors contributed equally to this work
*Correspondence: taghertp@pcg.wustl.eduof neuropeptide- and/or neurohormone-encoding genes, all
peptidergic NE cells nevertheless share many critical cellular
functions. These functions reflect a common need for enzymes
that conduct the posttranslational processing of numerous
neuropeptide precursors and a need for the structural and
regulatory components that execute large dense-core vesicle
(LDCV) biogenesis, packaging, maturation, and trafficking
[1, 2]. They also exhibit a choreographed capacity to modify
their cell properties in response to changing physiological
needs [3]. Many proteins are normally enriched in neuroendo-
crine tissues, and these may be coordinately regulated under
different physiological states [4, 5]. Hence, NE programs of
cell differentiation must reflect the operations of complex
regulatory circuits, the details of which are only beginning to
emerge. Examining the intracellular regulatory pathways that
organize and modulate these specialized properties is an
important question for cell biology and specifically is also
critical to understanding NE cell physiology.
Important clues to understanding peptidergic cell biology
may come from parallel studies of other neuronal secretory
systems. Developmental programs of neurotransmitter ex-
pression are governed by dedicated transcriptional orga-
nizers. For example, serotonergic neuron differentiation (but
not fate specification or survival) is substantially controlled
by an ETS-domain transcription factor called PET-1 [6]. Like-
wise, dopaminergic (DA) neuron maturation is promoted by
the ETS transcription factor AST-1, although it is not necessary
for DA neuron generation or survival [7]. To what extent, there-
fore, do peptidergic secretory cells rely on similar transcrip-
tional regulatory controls?
In the Drosophila model system, the transcription factor
DIMM operates in peptidergic NE cells in many ways similar
to PET-1 and AST-1 in aminergic cells. DIMM is specifically
expressed in peptidergic NE cells [8–12]—termed LEAP cells
(large, episodically releasing, amidating peptide producing)
[13]. Notably, DIMM acts like amaster cell regulator for profes-
sional secretory cell properties. It confers two cardinal fea-
tures of the regulated secretory pathway (RSP) [14] onto
neurons that otherwise do not display such properties [15].
The first property is generation and accumulation of LDCVs,
which can house neuropeptides if these are available. The
second property is activation of the complete posttransla-
tional processing machinery, which is sufficient to produce
biologically active peptides from neuropeptide precursors.
These cell biological observations raise important questions
as to how DIMM, a single transcription factor, can efficiently
organize a complete and functional subcellular domain like
the RSP. We reasoned that direct targets provide the most
compelling basis to describe DIMM action mechanisms.
Here we report a genome-wide screen to define candidate
targets for DIMM regulation.
Results
Identification of Candidate Genes as Putative Direct
DIMM Targets
To amass candidate DIMM targets in addition to peptidylgly-
cine a-hydroxylating monooxygenase (Phm) [12], we used
Figure 1. Schematic Overview of Workplan for This Study
A genome-wide search for dimm targets was performed by gene chip, and the results then were evaluated by three downstream analyses of DIMM
regulation and a functional in vivo assay.
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1516genome-wide microarray profiling by overexpressing DIMM
throughout the embryonic nervous system. To identify upregu-
lated transcripts, we compared profiles from experimental
(elav>dimm) and control (elav-GAL4) embryos at 22–26 hr
and 28–32 hr after egg laying. We identified 134 candidate
DIMM targets that were upregulated at least 1.5-fold following
DIMM overexpression at both time points (see Table S3 avail-
able online). Many genes were also downregulated (Table S4),
but we did not study these further.
We used quantitative real-timePCR to confirm that 22 candi-
date targets were upregulated at least 1.5-fold by DIMM over-
expression, and of these, 18 genes were upregulated at least
2-fold (Table S5). Many of the 134 candidates were not tested
based on low expression levels, were tested but not detected
by qPCR at this stage, or had primer sets that failed quality-
control tests. Finally, we focused on the 18 most highly
elevated transcripts and reasoned that as DIMM targets,
they would be expressed in the central nervous system
(CNS), and their RNA levels would decline in a dimm loss-of-
function mutant. Using conventional PCR, we found that tran-
scripts of all 18 genes were in fact expressed in CNS (Table
S5). In addition, in first-instar larvae of severe dimm hypo-
morphs (Rev4/Rev8; [8]), transcript levels for 11 of the 18
genes were significantly decreased. We therefore focused on
these 11 genes; their identities and GO terms are listed in
Table S6.
Two of the eleven candidates, Phm andCG1275, were previ-
ously associated with peptidergic signaling. Consistent with
previous findings, the inclusion of Phm provides internalvalidation to the profiling method. CG1275 encodes a cyto-
chrome (Cyt) transmembrane electron transporter most
related to the b561-1 protein [16]. Cyt b561-1 is specific to
dense-core secretory vesicles that contain catecholamines
or amidated peptides, as are found in chromaffin cells and
elsewhere. Cyt b561-1 regenerates ascorbate, which is an
essential cofactor to support the biosynthetic functions of
PHM [17, 18] from within the vesicles.
Evaluating the Eleven Candidate DIMM Targets
We performed three independent experiments to evaluate the
degree to which the 11 candidate targets are strongly regu-
lated by DIMM and devised a functional screen to determine
the potential contributions of the candidates to DIMM action
mechanisms. Figure 1 presents an overview of the work
plan. As summarized in Table 1 and argued in the Discussion,
these experiments suggest that the 11 targets are divisible into
a ‘‘strongly regulated’’ set of six genes (direct regulation), two
additional genes that may be directly targeted, and another set
of three likely indirect targets.
Experiment I: Embryonic RNA In Situ Hybridization
We first analyzed transcript distributions for each of the 11
candidates in embryos of diverse stages and of two different
genotypes (control and elav>dimm; see Supplemental Exper-
imental Procedures for precise genotypes). Representative
specimens are shown in Figure 2; control specimens are on
the left and dimm overexpression specimens are on the right
of each column. By stage 16–17 in control embryos, we ob-
served a clear cell-specific pattern of dimm transcripts in the
Table 1. Summary of Results to Determine the Validity of Eleven Candidate Direct DIMM Genes
Gene
Embryo In Situa
Transactivation
in Cell Culture
Adult
In Vivo ChIPb
Adult
In Vivo RNAi/MS
Enriched in Adult
DIMM Neuronsc ConclusionControl Dimm-OVX
CG3832 (Phm) + ++ ++ ++ + + direct
CG1275 (Cyt b561-1) 2 ++ ++ ++ + + direct
CG13248 (CAT-4) + ++ ++ + + + direct
CG11254 (mael) 2 ++ ++ + 2 + direct
CG17293 (wdr-82) + ++ ++ + 2 + direct
CG7785 (CLLD6) + ++ 2 + 2 + direct
CG6522 + +d ++ ++ 2 2 maybe direct
CG32850 (RNF-11) + ++ 2 + 2 2 maybe direct
CG14621 (Slc35e1) 2 2 2 + 2 2 indirect
CG31346 2 2 ND + ND 2 indirect
CG8588 (pastrel) 2 2 2 2 2 2 indirect
a2, no expression; +, moderate expression detected; ++, strong expression detected; ND, not determined.
b ++p < 0.05; +, positive but not surpassing statistical significance.
cGreatly enriched in DIMM-positive l-LNvs versus s-LNvs [26].
dNo obvious change.
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1517CNS ([8]; Figure 2A). Upregulation of dimm by elav-GAL4
produced the expected panneuronal activation of dimm tran-
scripts (Figure 2A0). Transcripts for the only previously known
direct DIMM target, Phm, displayed a moderate level of
expression in control embryonic tissues (Figure 2B) and clear
upregulation with DIMM overexpression (Figure 2B0), although
the upregulation was not as pronounced as the one shown by
dimm transcripts.
Seven other candidates (CG1275, CG13248, mael
[CG11254], CG17293, CG7785, CG32850, and CG6522) dis-
played weak tomoderate expression levels in control embryos
(Figures 2C–2H). In the case of CG6522, transcripts wereFigure 2. RNA In Situ Hybridization in Control Embryos and Embryos that Ove
(A–H) Control (w1118).
(A0–H0) elav>dimm.
The following probes were used: dimm (A and A0), Phm (B and B0), CG1275 (C a
CG7785 (G and G0), and CG32850 (H and H0). See also Figure S1.moderately to broadly expressed in normal tissues and were
modestly increased with dimm overexpression (data not
shown). None of these candidate targets displayed a normal
expression pattern exactly matching that of dimm. CG13248
(Figure 2D) and CG32850 (Figure 2H) were broadly expressed
with very prominent accumulation in paired midline cells of the
ventral nerve cord. In the case of Phm and CG13248, those
patterns were present early (circa stage 13) but resolved to
a stronger staining pattern in lateral CNS regions later in
embryogenesis that resembled that of dimm (Figure S1).
mael (CG11254) transcripts were not clearly detected in
normal CNS (Figure 2E), although we clearly observed maelrexpress dim
nd C0), CG13248 (D and D0), CG11254 (mael) (E and E0), CG17293 (F and F0),
Figure 3. Transactivation by DIMM of Genomic Fragments of Candidate
Genes in Drosophila BG3-c2 Neuronal Cell Lines
Fold ratios represent luciferase levels with dimm cotransfection divided by
those without. Histograms represent means and standard errors of the
mean (SEMs) of at least three independent replicate assays.
(A) Results of testing ten DIMM targets. *p < 0.05; **p < 0.01 versus empty
vector by Student’s t test.
(B) Results from analysis of E box sequence requirements within the
CG13248 regulatory region. E1, E2, and E3 indicate three separate E boxes,
which weremutated singly, doubly, or triply. *p < 0.01 versusCG13248wild-
type sequence by Student’s t test.
See also Figure S3, which illustrates E box positions in and around these
candidate targets.
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1518in normal germ cells (cf. [19]). CG17293was weakly expressed
throughout the CNS (Figure 2F), and CG7785 was moderately
expressed (Figure 2G).
DIMM overexpression resulted in heightened target RNA
accumulation for 7 of the 11 candidate targets. The dimm-
stimulated transcript patterns varied but did show some simi-
larities: most prominently, many patterns included heavy
accumulation in the paired midline cells (Figures 2B0–2E0,
2G0, and 2H0). Such midline cells do not normally express
high levels of dimm (Figure 2A). Transcripts for the three other
candidate targets (CG14621, CG31346, and pastrel [CG8588])
were not detectable in control CNS (although some were
evident in nonneuronal tissues). Likewise, we could not detect
them following dimm overexpression (data not shown).
In summary, 7 of the 11 candidate genes are regulated by
DIMM according to embryonic-stage in situ hybridization
experiments—Phm, Cyt b561-1, CG13248, mael, CG17293,
CG7785, and CG32850.
Experiment II: In Vitro Transactivation Assay
Our second test for strength of regulation measured DIMM’s
ability to transactivate regulatory fragments of the candidate
gene targets using luciferase levels as a readout.Wegenerated
test constructs containing the luciferase reporter downstream
of a mini-SV promoter and the putative DIMM-binding locus
of the gene. Putative DIMM-binding sites were selected by
the presence and locations of specific E box sequences
(CATATG or CAGCTG) based on our previous analysis [12];
therefore, we focused especially on E boxes within the first
intron. Most candidate genes contained either CATATG or
CAGCTG E box sequences throughout the gene locus
(Figure S2). In addition, we also combined the data from chro-
matin immunoprecipitation (ChIP) analysis (see below).
Although our earlier work on DIMM regulation of Phm utilized
mammalian HEK293 cells [12], we wished to approximate
amorehomologous cellular context andso testedaDrosophila
neuronal cell line, BG3-c2 [20]. First, we confirmed that the
positive control (Phm-sv-Luc) displayed the expected respon-
siveness (w10-fold induction) when dimm was cotransfected,
but not when a mutant dimm isoform was cotransfected,
results consistent with our previous observations [12]. Next,
we measured dimm responsiveness for each of the candidate
genes. We found that in addition to Phm, five candidate
DIMM targets (CG1275, CG13248, mael, CG17293, and
CG6522) all displayed significant transactivation responses
to DIMM (Figure 3).
To evaluate DIMM transactivation in more detail, we con-
structed a series of sequence variants of theCG13248-respon-
sive fragment—the w1 kb fragment that comprises the first
intron and contains three E boxes. We mutated three of the
six consensus bases of the E boxes and tested each mutated
E box in single, double, and triple format; the positions of the E
boxes and the results obtained are shown in Figure 3B. Once
again, the wild-type CG13248 sequence produced an activity
level comparable to that of Phm. Of the three single E box
mutations, only E3 proved necessary for full DIMM transacti-
vation. Furthermore, all mutant combinations containing the
E3 mutation were not transactivated. Finally, the E1/E2 double
mutant showed a diminished level of transactivation. In
summary, the evidence points to the involvement of multiple
E boxes in the transactivation of CG13248, with the E3
sequence playing the largest role.
Experiment III: In Vivo Chromatin Immunoprecipitation
To determine the potential occupancy by DIMM at candidate
target gene binding sites in vivo, we used an epitope-tagged
Figure 4. ChIP Analysis In Vivo of Putative DIMM Binding at E Boxes within
dimm-Dependent Candidates Genes
Black bars show the level of enrichment of the putative DIMM-binding
sites defined by the value in experimental versus control genotypes (see
Supplemental Experimental Procedures). Gray bars show the level of
enrichment of arbitrarily chosen sites w6 kb upstream of the putative
DIMM-binding sites, in the same experimental versus control genotypes.
Histogram represents average and SEMs at least two independent assays
(two biological replicates).
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1519dimm transgene and ChIP methods. The transgene—UAS-
dimm-MYC (II)—was selectively expressed in dimm-contain-
ing neurons by using the c929-GAL4 driver. Furthermore, we
restricted GAL4-UAS activities to adult stages by using
temperature-sensitive GAL80 (tub-gal80ts) to avoid the lethality
that results from dimm overexpression at earlier stages (T.H.,
unpublished data). After raising the flies at the restrictive
temperature (18C), 1- to 3-day-old adults were transferred
to 29C for a 3-day period to permit expression of DIMM-
MYC protein. We confirmed DIMM-MYC expression under
these conditions by western blot analysis of fly head extracts
and an absence of such without transfer to 29C (data not
shown).
In a previous report, we demonstrated that DIMM activates
Phm directly via three palindromic E boxes (with sequences
CATATG and CAGCTG) that are located in the Phm first intron
[12]. Therefore, as a positive control, we asked whether DIMM
is resident at thisPhm intron and took a comparative approach
by testing each of two sites in the Phm gene locus for DIMM
occupancy—the E box-containing test site within the first
intron and a control site located about 6 kb upstream (see Fig-
ure S2; control sites are listed in Table S2). Across two biolog-
ical replicates, DIMM-MYC ChIPed samples for the Phm gene
showed a strong (w32-fold) average enrichment over samples
from the negative control genotype (c929-GAL4; tub-gal80ts).
This difference was significantly different (p < 0.05) from the
average enrichment found at its negative control site. We
then asked whether DIMM is resident at the other target genes
in vivo and selected test sites based on inclusion of potential
DIMM-binding E boxes in the immediate 50 upstream or first
intronic regions. Two of these candidates displayed a sta-
tistically higher level of enrichment compared to controls—
CG1275 and CG6522. For seven other genes—CG13248,
CG11254 (mael), CG17293, CG7785, CG32850, CG14621,
and CG31436—we observed a trend for DIMM enrichment atthe E box-containing site (Figure 4; Table 1). However, these
seven other examples did not achieve statistical significance.
In summary, ChIP analysis suggests that DIMM protein is
normally resident in adult head DIMM cells in vivo in the regu-
latory DNA of at least three (Phm, CG1275, and CG6522) and
likely as many as 10 of the 11 candidate targets. Furthermore,
through all three independent tests of validation, 10 of 11
candidate target genes subsequently scored positive in at
least one independent assay for direct DIMM regulation
(summarized in Table 1). Five genes were responsive in all
three assays (Phm, CG1275, CG13248, mael, and CG17239),
and two others, CG7785 and CG6522, were responsive in
two of the assays. CG32850, CG14621, and CG31436 all
showed DIMM residency in vivo by ChIP, but of these three
candidates, only CG32850 also displayed mRNA induction
by DIMM in embryos. Only the eleventh candidate, pst, failed
to show significant responsiveness in any test.
Experiment IV: Adult In Vivo RNAi and LC-MS
To determine whether DIMM target genes contribute to its
action mechanisms, we devised a functional screen. We pre-
viously demonstrated that ectopic expression of DIMM in
photoreceptor neurons confers peptidergic neuroendocrine
properties onto them—photoreceptor neurons do not nor-
mally display such properties of the RSP. When such cells
are also forced to express a heterologous neuropeptide
precursor (ppMII), the MII peptide is fully processed [15]. We
therefore used the DIMM-dependent accumulation of pro-
cessed MII peptide as an endpoint assay to measure potential
contributions of single candidate targets to the DIMM-gener-
ated secretory pathway. We used transgenic RNA interference
(RNAi) methods to knock down individual DIMM targets exclu-
sively within photoreceptor cells and employed quantitative
mass spectrometry to analyze the processing of MII. In the
control condition (GMR>dimm;ppMII), fully processed MII
peptide is detected at 1710.69 m/z ratio [15]. To normalize
the results of MII peptide accumulation across conditions,
we also measured an endogenous Drosophila brain peptide,
not found in photoreceptors, as an internal standard. For
this, we chose the Drm-MT2 peptide derived from the Hugin
neuropeptide precursor (SVPFKPRLamide, m/z 942.59 [21]),
because hugin-expressing neurons do not express the RNAi
transgene in this experimental design. An additional negative
control in this design tested the effect of an RNAi transgene
for a neuropeptide precursor never found in photorecep-
tors—ecdysis-triggering hormone (eth) [8].
We used both labeling and label-free quantitative mass
spectrometry (MS) approaches to analyze MII and MT2 pep-
tide levels in Drosophila head extracts using capillary liquid
chromatography matrix-assisted laser desorption/ionization
time-of-flight (LC-MALDI-TOF/TOF) MS. The MS-based
labeling method is well validated [22, 23] but involves multiple
sample-handling steps and is less effective for samples with
low concentrations and small volumes. Although we were
able to quantify MT2 with the labeling approach (Figure S3),
MII was not observed after labeling. We therefore turned to
label-free quantitation because isolated peak heights can be
directly compared across conditions.
Using the label-free quantitation, MT2 levels showed equal
intensities in the control (GMR>dimm;ppMII) and experi-
mental (GMR>dimm;ppMII;Phm-RNAi) samples (Figure 5A),
consistent with labeling results (Figure S3). MII levels in the
experimental sample were significantly decreased from those
in the control sample (Figure 5B). MII levels were significantly
lower following knockdown of Phm, CG1275, and CG13248
Figure 5. MS-Based Label-Free Quantitative Analysis of Alterations in MII
Peptide Accumulation in Photoreceptors following RNA Interference of
Candidate DIMM Targets
(A) Mass spectra of MII in the control (GMR>dimm;ppMII, red) and experi-
mental (GMR>dimm;ppMII;Phm-RNAi, blue) samples. The intensity ratio
of MII in experimental versus control samples in these spectra is 0.54.
(B)MassspectraofMT2 in thecontrol andexperimental samples.The intensity
ratio of MT2 in experimental versus control samples in these spectra is 1.02.
(C) Exogenous MII level in the experimental samples with RNAi compared
to that in the control samples. Histogram represents means and SEMs;
*p < 0.05 versus control (GMR>UAS-dimm) by Student’s t test. n indicates
number of biological replicates.
See also Figure S3 for analysis of MS-based quantitation of the endogenous
peptide Drm-MT2.
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1520(Figure 5C). CG17293 RNAi displayed less fully processed
peptide, and CG11254 (mael) RNAi showed a trend of upregu-
lation, but their final values did not exceed statistical signifi-
cance. MII levels in the other six RNAi tests were unchanged.
In summary, 3 of 10 candidate DIMM targets (Phm, CG1275,
and CG13248) make critical contributions to DIMM mecha-
nisms. Two candidates (Phm and CG1275) are clearly involved
in processing, and CG13248 may additionally be involved in
overall organization of the secretory pathway (see Discussion).
The functional assay that we employedwas sensitive to distur-
bances of processing, but that is not the only interpretation for
a reduction in the level of the secretory peptide. A reduced
level could also result from an inability to accumulate, properly
traffic, or retain secretory peptides.Wedid not detect abuildup
of intermediates with CG13248 RNAi, and this likely indicates
a defect at a stage different from processing.
The CG13248 Protein Is Enriched in DIMM Neurons
and Dependent on dimm
CG13248 encodes a putative cationic amino acid transporter
orthologous to mammalian cationic amino acid transporter 4
(CAT-4; SLC7a4). We analyzed CG13248 protein expression
using anti-CAT-4 antibodies in both the adult brain and the
third-instar larval brain and evaluated it in the context of
DIMM expression.
First, we performed double immunostaining with dimm
neurons labeled by anti-GFP (in c929-GAL4>GFP brains). In
both developmental stages, CAT-4-like immunoreactivity (IR)
is heavily enriched in DIMM-positive neurons; Figure 6A shows
an example of an adult brain. We also noted minorities of
DIMM-only and CAT-4-only stained neurons. CAT-4-like IR
was foundmainly in cell bodies and terminals (data not shown)
but rarely within axonal tracts. CAT-4-like IR was specific as
shown by the action of a CG13248 RNAi transgenic construct:
when driven by 386y-GAL4, CAT-4-like IR was lost, whereas
DIMM-like IR was unaffected (Figures 6C and 6C0). 386y-
GAL4 is an insertion in the prohormone convertase gene
dPC2, and it drives expression in most or all dimm neurons,
as well as other cells [24].
We next asked whether CAT-4 expression is dependent on
DIMM in loss-of-function and gain-of-function dimm states.
We generated UAS-dimm RNAi flies, confirmed the ability of
these transgenes to produce a large-scale reduction of
DIMM-like IR (Figures 6D and 6D0), and observed a concomi-
tant reduction of CAT-4-like IR (Figures 6D and 6D0). This result
indicates that high-level CAT-4 expression in dimm-positive
neurons depends on DIMM. To test the effects of DIMM over-
expression, we turned to the four-cell Tv cluster of the larval
CNS. CAT-4-like IR is normally found in two of the four Tv
cluster neurons: the peptidergic Tv and Tvb but not the Tva
or Tvc neurons (Figure 6E; cf. [25]). We used an ap-GAL4 driver
to misexpress DIMM in all four Tv cells and observed ectopic
CAT-4-like expression within the Tva and Tvc cells as well (Fig-
ure 6F). These results confirm that in vivo CAT-4 is specifically
enriched in DIMM-positive cells and regulated by dimm. The
distribution of CAT-4-like immunoreactivity within DIMM neu-
rons was studied in various identified peptidergic neurons of
the adult brain (Figure S4), including diverse neurons of the
pars intercerebralis, HUG-positive neurons of the subesopha-
geal neuromeres, and PDF-positive large lateral neuron ventral
(l-LNvs). In these neurons, CAT-4-like IR was expressed
strongly by many DIMM neurons and weakly by others. It ap-
peared principally cytoplasmic and displayed heterogeneous
accumulations.
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Figure 6. Enrichment of CG13248 (CAT-4) in
DIMM Neurons and Its Regulation by dimm
In Vivo
(A) DIMM-like and CAT-4-like immunoreactivity
(IR) are extensively colocalized in the adult brain.
Genotype shown is c929>GFP. Anti-GFP is
shown in green and anti-CAT-4 in red; a merged
image is shown at the bottom.
(B–D0) CAT-4-like IR following RNAi knockdown
of dimm. Anti-CAT-4 is shown in red in (B)–(D);
anti-DIMM is shown in red in (B0)–(D0).
(B and B0) Parental control (386y-GAL4).
(C and C0) 386y>UAS-DCR2/UAS-CAT-4-RNAi.
(D and D0) 386y>DCR2/dimm-RNAi.
(E and F) CAT-4-like IR is normally present in the
two DIMM-positive neurons of the four-cell Tv
cluster; following DIMM misexpression through-
out the cluster, CAT-4 appears in all four cells.
(E) Genotype shown is ap>GFP. Anti-GFP is
shown in green and anti-CAT-4 in red.
(F) Genotype shown is ap>dimm. Anti-MYC
(which is an index for DIMM) is shown in green
and anti-CAT-4 in red. See also Figure S4 for
high-power images of cDAT-4-like IR in different
adult brain DIMM neurons.
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1521A Computational Analysis Afforded by Prior Transcript
Profiling of Mature DIMM Neurons
A recent microarray analysis of identified neurons from
the adultDrosophila brain provided a fortuitousmeans to inde-
pendently assess the authenticity of the original 134-gene
list [26]. Importantly, that study was conducted on wild-type
brains containing normal DIMM levels, and so it serves as
a useful counterpoint to our study of DIMM overexpression.
Kula-Eversole et al. [26] profiled two types of neurons—
l-LNvs and small lateral neuron ventral (s-LNvs). These two
identified neuron groups are similar in that both are circadianpacemakers and neuropeptide PDF-ex-
pressing cells [27]. However, they are
different in that only the l-LNvs are
DIMM-positive, whereas the s-LNvs
are not ([24]; Figure 7; see also [13]).
Kula-Eversole et al. [26] compared
l-LNvs and s-LNvs with a generic (ELAV-
positive) brain neuron type forw19,000
transcripts. Using that primary data
set, we identified 579 genes enriched in
l-LNvs over s-LNvs. By comparing our
134-gene list derived from DIMM over-
expression in embryonic stages to those
579 transcripts normally enriched in
DIMM-positive cells from adult stages,
we found an intersection of 18 putative
DIMM direct target genes specifically
enriched in adult l-LNvs versus s-LNvs
(Figure 7; Table S3). Significantly, the
six DIMM targets that we identified by
experimental analysis are all included
in this intersection—Phm, CAT-4, mael,
CG17293, CG7785, and Cyt b561-1.
Discussion
The experiments reported here address
the mechanisms underlying DIMM’sregulatory functions within peptidergic neuroendocrine cells
in Drosophila. The results from a genome-wide screening re-
vealed a diverse array of potential DIMM targets and illustrated
that the scope of DIMM actions is likely broad. The actions of
its direct targets appear to extend from the nucleus (CG17293)
to regulation of mRNAs (CG11254) to the endoplasmic retic-
ulum and Golgi (CG13248) to peptide-containing LDCVs
(Phm and CG1254). We found no neuropeptide-encoding
genes on any of our lists, even the larger 134-gene list of tran-
scripts exhibiting upregulation with DIMM overexpression. We
showedpreviously that DIMM is inefficient on its own at driving
Figure 7. Comparison of Transcripts Upregulated by DIMM in Embryos with Transcripts Enriched in DIMM-Positive Peptidergic Neurons of the Adult Brain
The Venn diagram illustrates the identification of 18 genes (13% of 134) out of those upregulated by DIMM overexpression among the 537 normally enriched
in DIMM-positive l-LNvs [29]. The list below the diagram shows the 18-gene intersection; red text indicates those genes that were shown to be direct DIMM
targets by the current experiments.
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findings are consistent with our previous speculation that in
Drosophila, specific neuropeptide expression is controlled
by differing sets of transcription factors working within
complex combinatorial codes [9, 13]. In contrast, DIMM
provides parallel instructions for the cell biological machinery
within which neuropeptides can be made, stored, and traf-
ficked [9, 13, 15].
Because we used an overexpression screen to generate
a primary list of candidate targets, it was important to authen-
ticate those results by reference to genes enriched in ‘‘normal’’
DIMM cells (i.e., cells in which DIMM levels were not artificially
manipulated). Wewere fortunate to have access such informa-
tion from the recently published gene array study of Kula-
Eversole et al. [26], from which we found that 13% of the 134
gene candidates were in fact highly enriched in DIMM-positive
neurons (versus DIMM-negative peptidergic neurons). Al-
though several candidates performed well in many of these
tests and exhibit properties of direct DIMM targets, most did
not score positive in all tests employed (only Phm, CG1275,
CG13248,CG11254, and CG17293 did so). The results empha-
size the importance of employing multiple tests to fully eval-
uate and properly interpret lists of regulated transcripts. Of
the 11 genes passing the first test, we then used diverse exper-
imental criteria to divide them into sets of six direct targets,
two likely direct targets, and three indirect targets (Table 1).
We emphasize that our categorization of direct targets is
based on highly stringent criteria and discuss here the signifi-
cance of the findings for neuroendocrine cell biology.Phm, Cyt b561-1, and CG13248 Are Key and Direct DIMM
Mediators
The inclusion of Phm and Cyt b561-1 genes in the original list of
11 candidates increased our confidence in the list’s authen-
ticity because both play well-established roles in LDCVs [18].
Furthermore, we had demonstrated previously that Phm is
a true transcriptional DIMM target both in heterologous cells
and in vivo [12]. Likewise, the subsequent strong performance
of Phm and Cyt b561-1 in all four downstream assays provided
further support for the validity of the experimental design to
identify authentic DIMM targets.
CG13248 Is a Direct DIMM Target and Encodes a Putative
Arginine Transporter, CAT-4
In addition to Phm and Cyt b561-1, these studies show that a
third bona fide DIMM target gene, CG13248, is critical to
normal regulation of neuroendocrine cell properties. Notably,
in the results reported by Kula-Eversole et al. [26], Phm, Cyt
b561-1, and CG13248 all ranked near the top for absolute tran-
script abundance in DIMM-positive neurons. The identification
of CG13248 as an integral component of neuroendocrine
physiology is a significant new finding, but its specific contri-
bution is a mystery because its precise molecular functions
are not known. It is the clear sequence ortholog to mammalian
cationic amino acid transporter 4 (CAT-4) and is therefore
a candidate member of the system y+ (Na+- and pH-indepen-
dent) cationic amino acid-preferring transport activities [28].
CAT proteins form a branch of the solute carrier family 7
(SLC7) [29]. Murine CAT-1, -2, and -3 all display arginine
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1523transporter activity when heterologously expressed, but to
date, CAT-4 does not [30]. Notably, the Drosophila ortholog
of the CAT-1 protein is the transporter Slimfast, which medi-
ates arginine transport in fat body and acts as a nutrient sensor
[31]. In murine pancreatic acinar cells (which are regulated by
the DIMM ortholog MIST1 [32]), CAT-4 is a membrane-associ-
ated protein of secretory granules [33]. Future pursuit of the
exact mechanisms by and pathways in which CAT-4 operates
in DIMM-expressing neurons will help to illuminate funda-
mental neuroendocrine cell physiology.
Additional Direct DIMM Targets
Regarding the other direct DIMM targets, wemention a few for
potential novel insights into mechanisms of neuroendocrine
cell regulation. By transcript profiling, Kula-Eversole et al.
[26] reported that CG11254 (maelstrom [mael]) is highly en-
riched in the DIMM-positive l-LNvs. In germ cells, Mael local-
izes components of the microRNA pathway and contributes
to cellular polarization [19]. CG17293 encodes a protein highly
related to mammalian WDR82, and CG7785 encodes a protein
highly related to CCLD6—both of which suggest a connection
of DIMM mechanisms to chromatin-modifying properties [34].
There were two genes that we concluded to be likely directly
targeted (Table 1, ‘‘maybedirect’’).CG6522encodes amember
of the Testin/Prickle family of proteins. Notably, the Prickle-
like protein RILP interacts with REST and acts as a nuclear
translocation factor [35]. The significance of potential
Prickle-REST interactions is that REST displays a suppressive
effect on neurosecretory properties of PC12 cells (e.g., [36]). In
addition, CG32850 encodes a protein orthologous to RING
finger protein 11, which is a membrane-associated E3 ligase
expressed widely in brain [37]. Finally, in the larger list of 18
genes representing the intersection of the embryonic and adult
DIMM-regulated transcripts (Figure 1), there was sizable
representation of genes encoding proteins previously impli-
cated in regulated neuropeptide secretion (Rph) and probable
elements of the secretory pathway (PPADC1, RCN2, and
Rabx4).
DIMM Directs a Core Program for Neuroendocrine Cells
These results define principal elements of what we anticipate
will be a core program for neuroendocrine cell organization.
Among mammalian basic-helix-loop-helix proteins, DIMM is
most similar toMIST1 [32]. Mills and colleagues have identified
several candidate MIST1 targets, including RAB3D [38]. We
note that five of the six DIMM targets that responded to
DIMM in the transactivation assay contained E boxes in their
first exon-intron regions. The importance of first-intron E
boxes has already been established for the case of Phm [12]
and is also true for MIST1 target genes identified thus far
[38]. Furthermore, studies of Phm and CG13248 suggest that
they can define a consensus DIMM binding profile: they both
contain three boxes within the first intron, two of which have
the sequence CATATG, all of which contribute synergistically,
and one of which appears to have the strongest contribution to
DIMM transactivation. We predict that many other DIMM
targets will display a similar E box profile. Furthermore, how
individual target gene products contribute to the DIMM pro-
gram and how many more genes are involved are now
pertinent questions that will require additional studies. We
anticipate that further analysis of this core DIMM program
will help explain the regulatory organization of neuroendocrine
cells and their evolution in different phyla. Because DIMM
protein persists for the life of neuroendocrine cells inDrosophila, this work may also inform studies of neuroendo-
crine cell physiology and plasticity.
Developmental Generation of Peptidergic Phenotypes
In the case of neurons that utilize fast conventional neuro-
transmitters, transcriptional regulatory systems typically exert
direct control over genes that encode biosynthetic enzymes,
as well as ones for key transporter proteins that retrieve and
recycle transmitters back into the lumen of synaptic vesicles
[39]. For example, PET-1 supports serotonergic differentiation
and directly targets genes that encode the critical biosynthetic
enzyme TBH-1 and the serotonin transporter SERT1 [6]. It is
striking, therefore, that our limited but highly validated list of
DIMM targets similarly includes genes essential for neuropep-
tide biosynthesis (Phm and Cyt b561-1) as well as a transporter
that is specifically expressed by neuroendocrine cells (CAT-4).
We propose that there may exist an unexpected but essential
parallelism in the developmental regulation of secretory sys-
tems for small transmitters and small amidated peptides.
This hypothesis can help design experiments to further illumi-
nate the mechanisms that underlie the developmental genera-
tion of peptidergic phenotypes.
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